{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:41:34Z","timestamp":1778564494948,"version":"3.51.4"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T00:00:00Z","timestamp":1437350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0128695","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T17:59:11Z","timestamp":1437415151000},"page":"e0128695","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Salvia Miltiorrhiza Root Water-Extract (Danshen) Has No Beneficial Effect on Cardiovascular Risk Factors. A Randomized Double-Blind Cross-Over Trial"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct01563770","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Pleun C. M.","family":"van Poppel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Breedveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evertine J.","family":"Abbink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hennie","family":"Roelofs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waander","family":"van Heerde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Smits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaitje H.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans G.","family":"Russel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogier","family":"Donders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cees J.","family":"Tack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard A.","family":"Rongen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,7,20]]},"reference":[{"key":"ref1","unstructured":"Organization WH. The top 10 causes of death in the world, 2000 and 2012. Fact sheet N<sup>o<\/sup> 310; updated May 2014 2014 [cited 2015 March 23]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/mediacentre\/factsheets\/fs310\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/mediacentre\/factsheets\/fs310\/en\/<\/ext-link>."},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"R Ross","year":"1999","journal-title":"The New England journal of medicine"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0002-9149(76)90061-8","article-title":"A general cardiovascular risk profile: the Framingham Study","volume":"38","author":"WB Kannel","year":"1976","journal-title":"The American journal of cardiology"},{"issue":"14","key":"ref4","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/archinte.164.14.1490","article-title":"A practical and evidence-based approach to cardiovascular disease risk reduction","volume":"164","author":"TJ Gluckman","year":"2004","journal-title":"Archives of internal medicine"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4065\/84.8.741","article-title":"Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach. Mayo Clinic proceedings","volume":"84","author":"JH O'Keefe","year":"2009","journal-title":"Mayo Clinic"},{"issue":"8693","key":"ref6","first-page":"827","article-title":"Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context","volume":"335","author":"R Collins","year":"1990","journal-title":"Lancet"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jep.2013.06.050","article-title":"The rise of traditional Chinese medicine and its materia medica: a comparison of the frequency and safety of materials and species used in Europe and China","volume":"149","author":"EM Williamson","year":"2013","journal-title":"Journal of ethnopharmacology"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jacc.2009.07.074","article-title":"Use of herbal products and potential interactions in patients with cardiovascular diseases","volume":"55","author":"A Tachjian","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1177\/0091270005282630","article-title":"Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use","volume":"45","author":"L Zhou","year":"2005","journal-title":"Journal of clinical pharmacology"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/00498250701230559","article-title":"Role of ATP-binding cassette drug transporters in the intestinal absorption of tanshinone IIB, one of the major active diterpenoids from the root of Salvia miltiorrhiza","volume":"37","author":"XY Yu","year":"2007","journal-title":"Xenobiotica; the fate of foreign compounds in biological systems"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijcard.2007.01.004","article-title":"Cardiovascular effects of Danshen","volume":"121","author":"TO Cheng","year":"2007","journal-title":"International journal of cardiology"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.chroma.2008.12.032","article-title":"Advancement in analysis of Salviae miltiorrhizae Radix et Rhizoma (Danshen)","volume":"1216","author":"YG Li","year":"2009","journal-title":"Journal of chromatography A"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijcard.2004.10.052","article-title":"Chinese herbs Danshen and Gegen modulate key early atherogenic events in vitro","volume":"105","author":"DP Sieveking","year":"2005","journal-title":"International journal of cardiology"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/CS20100441","article-title":"Chinese herbal extracts (SK0506) as a potential candidate for the therapy of the metabolic syndrome","volume":"120","author":"Y Tan","year":"2011","journal-title":"Clinical science"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1089\/acm.2008.0436","article-title":"The quality of randomized controlled trials on DanShen in the treatment of ischemic vascular disease","volume":"15","author":"S Yu","year":"2009","journal-title":"Journal of alternative and complementary medicine"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004295.pub3","article-title":"Dan Shen agents for acute ischaemic stroke","volume":"2","author":"B Wu","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"ref17","first-page":"CD004465","article-title":"Danshen (Chinese medicinal herb) preparations for acute myocardial infarction","volume":"2","author":"T Wu","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0895-7061(02)03154-0","article-title":"Effect of AT1 receptor blockade on endothelial function in essential hypertension","volume":"16","author":"AU Klingbeil","year":"2003","journal-title":"Am J Hypertens"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/08038020410016548","article-title":"Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients","volume":"1","author":"A Zanchetti","year":"2004","journal-title":"Blood Press Suppl"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF00051113","article-title":"Effect of ACE inhibitors on endothelial dysfunction: unanswered questions and implications for further investigation and therapy","volume":"10","author":"B Pitt","year":"1996","journal-title":"Cardiovascular drugs and therapy \/ sponsored by the International Society of Cardiovascular Pharmacotherapy"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1291\/hypres.25.365","article-title":"Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension","volume":"25","author":"YK On","year":"2002","journal-title":"Hypertens Res"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"WT Friedewald","year":"1972","journal-title":"Clinical chemistry"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"DR Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0891-5849(01)00519-6","article-title":"Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers","volume":"30","author":"LJ van Tits","year":"2001","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of &quot;antioxidant power&quot;: the FRAP assay","volume":"239","author":"IF Benzie","year":"1996","journal-title":"Anal Biochem"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/01.HYP.25.5.918","article-title":"Measuring forearm blood flow and interpreting the responses to drugs and mediators","volume":"25","author":"N Benjamin","year":"1995","journal-title":"Hypertension"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/cs0800413","article-title":"Role of the wrist cuff in forearm plethysmography","volume":"80","author":"J Lenders","year":"1991","journal-title":"Clinical science"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1152\/jappl.1997.83.6.1785","article-title":"Nitric oxide and vasodilation in human limbs","volume":"83","author":"MJ Joyner","year":"1997","journal-title":"J Appl Physiol (1985)"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1179\/102453311X13085644680348","article-title":"A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis","volume":"16","author":"M van Geffen","year":"2011","journal-title":"Hematology"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Senn S (2002) Cross-over trials in clinical research. Vol 5 JWS.","DOI":"10.1002\/0470854596"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jpba.2005.12.032","article-title":"Improved quality control method for Danshen products\u2014consideration of both hydrophilic and lipophilic active components","volume":"41","author":"L Zhou","year":"2006","journal-title":"Journal of pharmaceutical and biomedical analysis"},{"issue":"21","key":"ref32","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198911233212103","article-title":"The effect on serum cholesterol levels of coffee brewed by filtering or boiling","volume":"321","author":"AA Bak","year":"1989","journal-title":"The New England journal of medicine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0022-2275(20)41169-1","article-title":"Identity of the cholesterol-raising factor from boiled coffee and its effects on liver function enzymes","volume":"35","author":"MP Weusten-Van der Wouw","year":"1994","journal-title":"Journal of lipid research"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2796.1991.tb00447.x","article-title":"The hypercholesterolaemic factor in boiled coffee is retained by a paper filter","volume":"230","author":"I Ahola","year":"1991","journal-title":"Journal of internal medicine"},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199502233320801","article-title":"Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease","volume":"332","author":"CB Treasure","year":"1995","journal-title":"The New England journal of medicine"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0735-1097(03)00994-X","article-title":"The clinical implications of endothelial dysfunction","volume":"42","author":"ME Widlansky","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/01.CIR.101.9.948","article-title":"Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction","volume":"101","author":"JA Suwaidi","year":"2000","journal-title":"Circulation"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/01.CIR.0000025404.78001.D8","article-title":"Prognostic value of coronary vascular endothelial dysfunction","volume":"106","author":"JP Halcox","year":"2002","journal-title":"Circulation"},{"issue":"9753","key":"ref39","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"C Cholesterol Treatment Trialists","year":"2010","journal-title":"Lancet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0128695","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T16:04:36Z","timestamp":1652889876000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0128695"}},"subtitle":[],"editor":[{"given":"Cordula M.","family":"Stover","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,20]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0128695","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,20]]}}}